Jeremy Liu

Jeremy Liu, MD is a Physician Scientist at Yale University's Yale School of Medicine, Department of Ophthalmology & Visual Science. He holds an MD from the University of Hawaii John A. Burns School of Medicine and a BS in Healthcare Management from The University of Texas at Dallas. His research focuses on age-related macular degeneration (AMD), choroidal pathophysiology, and advanced imaging techniques like swept-source optical coherence tomography (SS-OCT). Dr. Liu has pioneered work on hyperreflective foci quantification, choroidal hypertransmission defects, and imaging biomarkers for AMD progression. He has published extensively in Am J Ophthalmol, Ophthalmology, and Invest Ophthalmol Vis Sci. Key contributions include defining novel clinical endpoints for AMD trials and characterizing calcified drusen effects on imaging. His work integrates clinical care with technological innovation in ophthalmic imaging.

• Education: MD - University of Hawaii (20XX), BS Healthcare Management - UT Dallas (20XX)
• Key Research Themes: Choroidal vascular dynamics, OCT angiography advancements, AMD biomarkers
• Awards: Alpha Omega Alpha Honor Medical Society (2020)
• Labs/Teams: Part of Yale's Ophthalmology imaging research group, collaborating with Luciano Del Priore and Philip Rosenfeld

Recent work emphasizes automated algorithms for drusen quantification and exploring phentermine's role in vascular occlusions. His research bridges basic science and clinical practice, aiming to improve AMD diagnosis and treatment monitoring.